These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17342091)

  • 1. Variation in the use of chemotherapy in lung cancer.
    Patel N; Adatia R; Mellemgaard A; Jack R; Møller H
    Br J Cancer; 2007 Mar; 96(6):886-90. PubMed ID: 17342091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy for lung cancer].
    Kurata T; Fukuoka M
    Nihon Rinsho; 2002 May; 60 Suppl 5():309-16. PubMed ID: 12101679
    [No Abstract]   [Full Text] [Related]  

  • 3. Histology-related variation in the treatment and survival of patients with lung carcinoma in Canada.
    Xie L; Ugnat AM; Morriss J; Semenciw R; Mao Y
    Lung Cancer; 2003 Nov; 42(2):127-39. PubMed ID: 14568680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pretreatment factors on adverse events: a pooled analysis of North Central Cancer Treatment Group advanced stage non-small cell lung cancer trials.
    Mandrekar SJ; Northfelt DW; Schild SE; Foster NR; Bot B; Marks RS; Mailliard JA; Krook JE; Maksymiuk AW; Adjei AA; Jett JR
    J Thorac Oncol; 2006 Jul; 1(6):556-63. PubMed ID: 17409917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing the use of antitumoral chemotherapy in the South East of England.
    Patel N; Ing L; Jack R; Moller H
    J Chemother; 2006 Jun; 18(3):318-24. PubMed ID: 17129845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bronchial cancer--adjuvant chemotherapy].
    Drings P
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():89-94. PubMed ID: 1983675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapy for lung cancer].
    Fujiwara K; Eguchi K
    Nihon Rinsho; 2000 May; 58(5):1087-92. PubMed ID: 10824554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of IGF-I and IGF-II in patients with lung cancer during chemotherapy.
    Izycki T; Chyczewska E; Naumnik W; Talalaj J; Panek B; Ossolinska M
    Exp Oncol; 2004 Dec; 26(4):316-9. PubMed ID: 15627066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy in cancer of the lung].
    Gütz S
    MMW Fortschr Med; 2006 Jun; 148(22):33-4. PubMed ID: 16821578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
    Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF
    Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study.
    De Ruysscher D; Botterweck A; Dirx M; Pijls-Johannesma M; Wanders R; Hochstenbag M; Dingemans AM; Bootsma G; Geraedts W; Simons J; Pitz C; Lambin P
    Ann Oncol; 2009 Jan; 20(1):98-102. PubMed ID: 18718891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Less toxic chemotherapy improves uptake of all lines of chemotherapy in advanced non-small-cell lung cancer: a 10-year retrospective population-based review.
    Ho C; Ramsden K; Zhai Y; Murray N; Sun S; Melosky B; Laskin J
    J Thorac Oncol; 2014 Aug; 9(8):1180-6. PubMed ID: 25157771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
    Strauss GM; Lynch TJ; Elias AD; Jacobs C; Herbst R; Leong T; Lynch C; Kwiatkowski DJ; Carey RW; Grossbard ML; Skarin AT
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definitive chemotherapy and radiotherapy in patients with stage II non-small cell lung cancer: A population-based outcomes study.
    Sampath S; Hall M; Schultheiss TE
    Lung Cancer; 2015 Oct; 90(1):61-4. PubMed ID: 26231092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gaps in optimal care for lung cancer.
    Vinod SK; O'Connell DL; Simonella L; Delaney GP; Boyer M; Peters M; Miller D; Supramaniam R; McCawley L; Armstrong B
    J Thorac Oncol; 2008 Aug; 3(8):871-9. PubMed ID: 18670305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ifosfamide-based chemotherapy for previously treated lung cancer patients.
    Chen YM; Liu JM; Wu MF; Wu HW; Lin WC; Tsai CM; Perng RP; Whang-Peng J
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):389-96. PubMed ID: 9699391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cigarette burden (measured by the number of pack-years smoked) negatively impacts the response rate to platinum-based chemotherapy in lung cancer patients.
    Duarte RL; Luiz RR; Paschoal ME
    Lung Cancer; 2008 Aug; 61(2):244-54. PubMed ID: 18243408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic-wide cDNA microarray screening to correlate gene expression profile with chemoresistance in patients with advanced lung cancer.
    Oshita F; Ikehara M; Sekiyama A; Hamanaka N; Saito H; Yamada K; Noda K; Kameda Y; Miyagi Y
    J Exp Ther Oncol; 2004 Jul; 4(2):155-60. PubMed ID: 15500010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of sFas and sFasL during chemotherapy of lung cancer.
    Naumnik W; Izycki T; Ossolinska M; Chyczewska E
    Exp Oncol; 2007 Jun; 29(2):132-6. PubMed ID: 17704746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Taxol in bronchial carcinoma].
    Gatzemeier U
    Med Klin (Munich); 1996 Dec; 91 Suppl 2():1-6. PubMed ID: 9082171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.